SEC
SlamSEC
SearchBrowseEarnings

AVADEL PHARMACEUTICALS PLC

Nasdaq:AVDL
Pharmaceutical Preparations·DUBLIN 2
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

Avadel Pharmaceuticals plc was an Irish specialty pharmaceutical company focused on sleep disorder medicines marketed for hospital and primary care treatments. Headquartered in Dublin, Ireland, it had operations in St.

CFO
Mchugh Thomas S
Revenue
$0
FY 2024
Adj. EBITDA
-$95.4M
FY 2024
Net Income
-$137.5M
FY 2024
EPS (Diluted)
-$2.29
FY 2024
Stock Price
$21.64
+0.0%
2026-02-11
52W Range
$6.38 – $23.57
P/E Ratio
-9.4x
Market Cap
$2.1B
Cash
$31.2M
FY 2024
Total Debt
$143.1M
FY 2022
Net Debt
$112.0M
FY 2022
Enterprise Value
$2.2B
Debt / EBITDA
-1.2x
FY 2024
EV / EBITDA
-23.3x
Employees
—